Discontinued — last reported Q2 '25
Finished goods
Current AssetsEli Lilly Finished goods increased by 14.2% to $1.55B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 38.9%, from $1.11B to $1.55B.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ2 2025
Parent metricInventories
How to read this metric
Rising levels relative to sales may indicate inventory buildup and potential future markdowns, while falling levels may signal strong demand.
Detailed definition
This represents the value of completed products ready for sale to customers. It is the final stage of the inventory cycl...
Peer comparison
Varies by business model; peers with just-in-time manufacturing will have lower levels than those with long supply chains.
Metric ID:
inv_finished_goodsHistorical Data
8 periods
| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $791.70M | $699.60M | $811.10M | $1.11B | $1.22B | $1.30B | $1.35B | $1.55B |
| QoQ Change | — | -11.6% | +15.9% | +37.3% | +9.6% | +6.3% | +4.4% | +14.2% |
| YoY Change | — | — | — | — | +54.2% | +85.6% | +67.0% | +38.9% |
| % of Inventories | 13.7% | 11.6% | 12.7% | 15.1% | 16.1% | 14.0% | 12.3% | 12.7% |
| Share Change | — | -2.1pp | +1.0pp | +2.4pp | +1.0pp | -2.1pp | -1.7pp | +0.4pp |
Range$699.60M – $1.55B
CAGR+46.6%
Avg YoY Growth+61.4%
Median YoY Growth+60.6%
Current Streak6 quarters growth
Finished goods at Other Companies
Frequently Asked Questions
- What is Eli Lilly's finished goods?
- Eli Lilly (LLY) reported finished goods of $1.55B in Q3 2025.
- How has Eli Lilly's finished goods changed year-over-year?
- Eli Lilly's finished goods increased by 38.9% year-over-year, from $1.11B to $1.55B.
- What does finished goods mean?
- The value of completed products that are ready to be sold.